ClinicalTrials.gg
CompletedNCT068203462MOTUpdated Feb 11, 2025

New Manual Test for Hip Abductor Extensibility

An interventional study of Manual and instrumental evaluation of hip adduction in Healthy, sponsored by Manusapiens. Completed at 1 site in Italy. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-11.

Sponsored by Manusapiens · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Oct 2022, registered Feb 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This pilot study aims to evaluate the precision and accuracy of a new manual test for assessing hip abductor extensibility. The iliotibial band (ITB) and hip abductor muscles play a crucial role in lower limb biomechanics, and their flexibility is commonly assessed using the Ober test. However, the Ober test has limitations, including excessive pelvic movement and reliance on qualitative evaluation. This study introduces and validates a novel manual test designed to improve the accuracy and reliability of hip abductor extensibility assessment.

The primary objective is to determine the intra-rater and inter-rater reliability of the new test, measured using the intraclass correlation coefficient (ICC). The secondary objective is to compare the test's accuracy against an inertial motion sensor system and to quantify pelvic movement during the new test. To provide a comparative measure of pelvic motion, a subgroup of participants will also undergo the modified Ober test.

Forty healthy participants (20 males and 20 females) aged 18 to 30 years will be recruited. Each participant will undergo the new test, performed by two independent raters. A subset of participants will also be evaluated using the modified Ober test to assess differences in pelvic movement. Inertial sensors will be used to measure hip adduction angles and pelvic motion. Statistical analyses will include ICC calculations for reliability and paired t-tests to compare pelvic movement between the tests.

This study aims to establish a more precise and objective method for evaluating hip abductor extensibility, which may enhance clinical assessment and management of conditions associated with iliotibial band tension.

Read the detailed description

This study aims to evaluate the reliability and accuracy of a new manual test for assessing iliotibial band (ITB) tension. The current standard for ITB extensibility assessment, the modified Ober test, presents limitations such as excessive pelvic movement and qualitative evaluation. The newly proposed test seeks to address these issues by minimizing extraneous movement and providing a more controlled and reproducible measurement of hip adduction.

Study Design The study follows a repeated-measures design, where intra-rater and inter-rater reliability are the primary outcomes, measured using the intraclass correlation coefficient (ICC). Secondary outcomes include the accuracy of the new test compared to an inertial motion sensor and an analysis of pelvic movement during the new test versus the modified Ober test in a subset of participants.

Participants A total of 40 healthy adults (20 males and 20 females), aged between 18 and 30 years, were recruited. The only exclusion criterion was the presence of symptomatic lower limb conditions that could interfere with the measurement, such as ligament injuries or degenerative joint diseases. No additional selection criteria were imposed, as existing literature does not categorize ITB extensibility based on age, sex, or pathology.

New Test Execution

The new test was originally proposed by Colonna (2012) and is designed to provide a more reliable and precise measurement of ITB tension. The test procedure consists of the following steps:

  • Patient Positioning: The patient lies supine on the edge of a treatment table, with the non-tested leg flexed at the hip and knee, stabilizing the pelvis by resting the lateral malleolus against the table edge. The tested leg remains extended.
  • Operator Positioning: The operator stands on the opposite side of the tested leg, stabilizing the knee of the non-tested leg with one hand and grasping the ankle of the tested leg with the other.
  • Hip Adduction: The tested leg is gently adducted until a determined resistance is felt or the patient reports discomfort, ensuring no pain occurs.
  • Measurement: The hip adduction angle is visually assessed and assigned a degree value.

This procedure is designed to enhance measurement accuracy by providing a clear and stable reference point while reducing the risk of excessive pelvic movement.

Modified Ober Test Execution A subset of participants underwent the modified Ober test for comparison. The patient lay on the side with the lower leg flexed at the hip and knee, while the upper leg remained extended. The therapist stabilized the pelvis while abducting and extending the hip, then allowing passive adduction. A goniometer was used to obtain quantitative measurements of hip adduction angles. The modified Ober test was chosen over the classic Ober test as it reduces the influence of knee flexors and patellar tension, providing a more specific assessment of ITB extensibility.

Phases of the Study

The study was conducted in six phases:

  • Agreement on Measurement Methodology: Standardization of the new test and the modified Ober test procedures.
  • Recruitment: Participants were enrolled at the OSCE (Osteopathic Spine Center Education) school of osteopathy in Bologna, Italy.
  • Training Phase: Operators practiced test execution using a goniometer and dynamometer (100N force standardization), validated their visual assessments with inertial sensors, and refined their technique.
  • Preliminary Testing for Agreement: Ten participants underwent preliminary tests to confirm measurement consistency.
  • Official Data Collection: Each operator conducted the new test on both lower limbs of each participant at two time points (T0 and T1), with a minimum four-hour interval. The modified Ober test was performed on 20 participants by one operator for pelvic movement comparison.
  • Data Analysis: Reliability and accuracy of the new test were assessed by comparing results to the modified Ober test and inertial sensor data.

Measurement Instruments

  • Hip adduction angles and pelvic rotation were measured using Xsens® inertial sensors. These wireless sensors, placed on the pelvis and thigh, provided real-time kinematic data to validate the accuracy of visual assessments and quantify pelvic movement.

Statistical Analysis

Data were analyzed using SPSS software. Reliability was assessed using ICC values, interpreted as follows:

Below 0.5: Poor reliability 0.5 to 0.75: Moderate reliability 0.75 to 0.9: Good reliability Above 0.9: Excellent reliability Accuracy of the new test was determined by comparing operator assessments with inertial sensor data. Paired t-tests were used to compare pelvic movement between the new test and the modified Ober test, with statistical significance set at p \< 0.05.

By addressing the limitations of the modified Ober test, this study seeks to introduce a more precise and clinically applicable method for assessing ITB extensibility.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Manusapiens is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy subjects

Exclusion criteria

Exclusion Criteria:

  • absence of symptomatic lower limb conditions that could impede measurement, such as ligament injuries of the knee or degenerative joint diseases of the hip
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Healthy adults

    Manual and instrumental evaluation of hip adduction

    Other: Manual and instrumental evaluation of hip adduction

Interventions

  • OtherManual and instrumental evaluation of hip adduction

    The intervention consists of a new manual test for assessing iliotibial band (ITB) tension and hip abductor extensibility. The patient lies supine on the edge of a treatment table with the non-tested leg flexed at the hip and knee, stabilizing the pelvis. The tested leg remains extended. The examiner stabilizes the non-tested leg with one hand and adducts the tested leg until a resistance is felt, ensuring no pain. The hip adduction angle is visually assessed and recorded. A subset of participants also undergoes the modified Ober test for comparison. Inertial motion sensors are used to validate the accuracy of visual assessments. The primary outcomes include intra-rater and inter-rater reliability, while secondary outcomes evaluate the test's accuracy and pelvic movement reduction.

06

What researchers measure

Primary outcomes

  1. Precison of visual hip adduction evaluation

    intra-day concordance intra and inter examiners of the visual identification of the degrees of hip adduction by means of intraclass correlation coefficient

    Time frame: 15 seconds for each evaluation (day 1)

  2. Accuracy of visual hip adduction evaluation

    Concordance intra-day between the visual and instrumental evaluation of the degrees of hip adduction. The instrumental data are obtained using a Xsens inertial sensors, which measure hip adduction angles. The sensor is placed on the shank of the tested leg, providing objective kinematic data. The concordance between the two methods is evaluated with the intraclass correlation coefficient.

    Time frame: 15 seconds for each evaluation (day 1)

Secondary outcomes

  1. Pelvis rotation during hip adduction evaluation

    Degrees of pelvis rotation during hip adduction evaluation measured with Xsens inertial sensors, both during the new test and the modified Ober test. The average values will be compared.

    Time frame: 15 seconds for each evaluation (day 1)

07

Study locations

1 site
  • Spine Center
    Bologna, 40128, Italy
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2022 to primary completion in Dec 2022, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2025
First posted
Feb 11, 2025
StartActual
Oct 1, 2022
Primary completionActual
Dec 1, 2022
CompletionActual
Mar 1, 2023
Last update
Feb 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06820346
Lead sponsor
Manusapiens
Responsible party
Sponsor
First posted
Feb 11, 2025
Start date
Oct 1, 2022
Primary completion
Dec 1, 2022
Completion
Mar 1, 2023
Last update
Feb 11, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion